BioCatalyst

NTHI — NEONC TECHNOLOGIES HOLDINGS, INC. catalysts

2 verified catalyst event(s) for NEONC TECHNOLOGIES HOLDINGS, INC. (ticker NTHI). Each is linked to its official source. Verified as of 2026-09-20.

Next verified catalyst

2026-11-30 — Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-11-30
in 2mo
ESTIMATED
 READOUT
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutat
Phase 1/2 · Glioblastoma Multiforme
 NTHI NEONC TECHNOLOGIES HOLDINGS, Perillyl alcohol ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
2026-12-30
in 3mo
ESTIMATED
 READOUT
NEO100 and High-Grade Meningioma
Phase 2 · Residual, Progressive or Recurrent Grade II or III Meningioma
 NTHI NEONC TECHNOLOGIES HOLDINGS, NEO100 ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.